Northern Trust’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119M | Sell |
225,430
-850
| -0.4% | -$392K | 0.01% | 710 |
|
|
2026
Q1 | $109M | Buy |
226,280
+7,367
| +3% | +$3.77M | 0.01% | 704 |
|
|
2025
Q4 | $123M | Sell |
218,913
-23,489
| -10% | -$13.3M | 0.02% | 653 |
|
|
2025
Q3 | $125M | Sell |
242,402
-94,267
| -28% | -$41.2M | 0.02% | 650 |
|
|
2025
Q2 | $106M | Sell |
336,669
-820
| -0.2% | -$246K | 0.01% | 687 |
|
|
2025
Q1 | $103M | Buy |
337,489
+89,347
| +36% | +$30.1M | 0.02% | 694 |
|
|
2024
Q4 | $82.4M | Buy |
248,142
+28,968
| +13% | +$9.82M | 0.01% | 818 |
|
|
2024
Q3 | $73.2M | Buy |
219,174
+3,140
| +1% | +$1.19M | 0.01% | 802 |
|
|
2024
Q2 | $89M | Buy |
216,034
+18,790
| +10% | +$7.44M | 0.02% | 685 |
|
|
2024
Q1 | $79.7M | Sell |
197,244
-29,885
| -13% | -$10.5M | 0.01% | 724 |
|
|
2023
Q4 | $69.6M | Sell |
227,129
-14,073
| -6% | -$3.8M | 0.01% | 794 |
|
|
2023
Q3 | $58.4M | Buy |
241,202
+9,192
| +4% | +$2.35M | 0.01% | 838 |
|
|
2023
Q2 | $55.7M | Sell |
232,010
-123,216
| -35% | -$25.6M | 0.01% | 888 |
|
|
2023
Q1 | $66.8M | Buy |
355,226
+1,321
| +0.4% | +$273K | 0.01% | 776 |
|
|
2022
Q4 | $75.2M | Sell |
353,905
-1,202
| -0.3% | -$240K | 0.02% | 692 |
|
|
2022
Q3 | $55.8M | Sell |
355,107
-29,770
| -8% | -$4.75M | 0.01% | 791 |
|
|
2022
Q2 | $57.6M | Sell |
384,877
-21,724
| -5% | -$3.14M | 0.01% | 806 |
|
|
2022
Q1 | $66.5M | Sell |
406,601
-20,494
| -5% | -$3.38M | 0.01% | 841 |
|
|
2021
Q4 | $93M | Sell |
427,095
-8,777
| -2% | -$1.84M | 0.02% | 692 |
|
|
2021
Q3 | $82.5M | Sell |
435,872
-6,793
| -2% | -$1.24M | 0.01% | 755 |
|
|
2021
Q2 | $78.2M | Sell |
442,665
-2,818
| -0.6% | -$486K | 0.01% | 809 |
|
|
2021
Q1 | $73.1M | Buy |
445,483
+17,634
| +4% | +$2.7M | 0.01% | 841 |
|
|
2020
Q4 | $59.6M | Sell |
427,849
-6,770
| -2% | -$853K | 0.01% | 939 |
|
|
2020
Q3 | $48.6M | Buy |
434,619
+53,849
| +14% | +$6.23M | 0.01% | 936 |
|
|
2020
Q2 | $35.4M | Buy |
380,770
+14,833
| +4% | +$1.26M | 0.01% | 1160 |
|
|
2020
Q1 | $26.9M | Buy |
365,937
+4,587
| +1% | +$398K | 0.01% | 1192 |
|
|
2019
Q4 | $30.4M | Sell |
361,350
-8,604
| -2% | -$666K | 0.01% | 1396 |
|
|
2019
Q3 | $31.1M | Buy |
369,954
+61,257
| +20% | +$4.63M | 0.01% | 1333 |
|
|
2019
Q2 | $20.2M | Buy |
308,697
+14,427
| +5% | +$831K | ﹤0.01% | 1691 |
|
|
2019
Q1 | $17.4M | Buy |
294,270
+4,286
| +1% | +$256K | ﹤0.01% | 1798 |
|
|
2018
Q4 | $15.3M | Buy |
289,984
+5,391
| +2% | +$296K | ﹤0.01% | 1787 |
|
|
2018
Q3 | $17.1M | Buy |
284,593
+100,548
| +55% | +$5.5M | ﹤0.01% | 1921 |
|
|
2018
Q2 | $7.91M | Buy |
184,045
+38,473
| +26% | +$1.55M | ﹤0.01% | 2415 |
|
|
2018
Q1 | $5.08M | Buy |
145,572
+23,334
| +19% | +$852K | ﹤0.01% | 2577 |
|
|
2017
Q4 | $4.43M | Buy |
122,238
+5,895
| +5% | +$207K | ﹤0.01% | 2682 |
|
|
2017
Q3 | $3.71M | Buy |
116,343
+14,615
| +14% | +$446K | ﹤0.01% | 2821 |
|
|
2017
Q2 | $2.95M | Buy |
101,728
+13,938
| +16% | +$391K | ﹤0.01% | 2932 |
|
|
2017
Q1 | $2.62M | Sell |
87,790
-15,060
| -15% | -$486K | ﹤0.01% | 2948 |
|
|
2016
Q4 | $3.71M | Buy |
102,850
+83,622
| +435% | +$2.79M | ﹤0.01% | 2744 |
|
|
2016
Q3 | $574K | Buy |
+19,228
| New | +$561K | ﹤0.01% | 3475 |
|
Other funds holding MEDP
WA
Northern Trust's MEDP Position: Q2 2026 in Review
Northern Trust reduced its Medpace (MEDP) stake by 0.38% in Q2 2026, selling an estimated $392K and leaving 225,430 shares worth $119M. The position accounts for 0.01% of the portfolio, ranked #710.
Northern Trust first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $125M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Northern Trust held 225,430 shares of Medpace worth $119M as of Q2 2026.
- Northern Trust sold 850 Medpace shares in Q2 2026, an estimated $392K.
- Medpace made up 0.01% of Northern Trust's portfolio in Q2 2026, its #710 holding.
- Northern Trust first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Northern Trust's Medpace position peaked at $125M in Q3 2025.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.